| Melanoma addiction to the long non-coding RNA SAMMSON E Leucci, R Vendramin, M Spinazzi, P Laurette, M Fiers, J Wouters, ... Nature 531 (7595), 518-522, 2016 | 578 | 2016 |
| Lung adenocarcinoma promotion by air pollutants W Hill, EL Lim, CE Weeden, C Lee, M Augustine, K Chen, FC Kuan, ... Nature 616 (7955), 159-167, 2023 | 431 | 2023 |
| Cancer evolution: Darwin and beyond R Vendramin, K Litchfield, C Swanton The EMBO journal 40 (18), e108389, 2021 | 219 | 2021 |
| Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA C Abbosh, AM Frankell, T Harrison, J Kisistok, A Garnett, L Johnson, ... Nature 616 (7957), 553-562, 2023 | 190 | 2023 |
| The evolution of lung cancer and impact of subclonal selection in TRACERx AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ... Nature 616 (7957), 525-533, 2023 | 179 | 2023 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 157 | 2023 |
| Non‐coding RNA s: the dark side of nuclear–mitochondrial communication R Vendramin, JC Marine, E Leucci The EMBO journal 36 (9), 1123-1133, 2017 | 130 | 2017 |
| Genomic–transcriptomic evolution in lung cancer and metastasis C Martínez-Ruiz, JRM Black, C Puttick, MS Hill, J Demeulemeester, ... Nature 616 (7957), 543-552, 2023 | 126 | 2023 |
| The evolution of non-small cell lung cancer metastases in TRACERx M Al Bakir, A Huebner, C Martínez-Ruiz, K Grigoriadis, TBK Watkins, ... Nature 616 (7957), 534-542, 2023 | 125 | 2023 |
| SAMMSON fosters cancer cell fitness by concertedly enhancing mitochondrial and cytosolic translation R Vendramin, Y Verheyden, H Ishikawa, L Goedert, E Nicolas, K Saraf, ... Nature structural & molecular biology 25 (11), 1035-1046, 2018 | 114 | 2018 |
| A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer Y Wu, D Biswas, I Usaite, M Angelova, S Boeing, T Karasaki, S Veeriah, ... Nature cancer 3 (6), 696-709, 2022 | 84 | 2022 |
| Evolutionary characterization of lung adenocarcinoma morphology in TRACERx T Karasaki, DA Moore, S Veeriah, C Naceur-Lombardelli, A Toncheva, ... Nature medicine 29 (4), 833-845, 2023 | 57 | 2023 |
| Body composition and lung cancer-associated cachexia in TRACERx O Al-Sawaf, J Weiss, M Skrzypski, JM Lam, T Karasaki, F Zambrana, ... Nature medicine 29 (4), 846-858, 2023 | 55 | 2023 |
| Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4/U6 recycling factor SART3 L De Troyer, P Zhao, T Pastor, MF Baietti, J Barra, R Vendramin, R Dok, ... Nucleic acids research 48 (5), 2502-2517, 2020 | 49 | 2020 |
| The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance DR Caswell, P Gui, MK Mayekar, EK Law, O Pich, C Bailey, J Boumelha, ... Nature Genetics 56 (1), 60-73, 2024 | 43 | 2024 |
| Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma R Vendramin, V Katopodi, S Cinque, A Konnova, Z Knezevic, S Adnane, ... Journal of Experimental Medicine 218 (9), 2021 | 42 | 2021 |
| Targeted chemotherapy overcomes drug resistance in melanoma J Yue, R Vendramin, F Liu, O Lopez, MG Valencia, HG Dos Santos, ... Genes & development 34 (9-10), 637-649, 2020 | 37 | 2020 |
| The cancer-specific lncRNA LISR customizes ribosomes to suppress anti-tumour immunity S Cinque, Y Verheyden, V Katopodi, Z Knezevic, E Demesmaeker, ... BioRxiv, 2023.01. 06.523012, 2023 | 7* | 2023 |
| Transcriptome dynamics of the microRNA inhibition response J Wen, E Leucci, R Vendramin, S Kauppinen, AH Lund, A Krogh, ... Nucleic Acids Research 43 (13), 6207-6221, 2015 | 5 | 2015 |
| Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages Y Zhao, J Gao, J Wang, F Fan, C Cheng, D Qian, R Guo, Y Zhang, T Ye, ... Nature Communications 15 (1), 7928, 2024 | 2 | 2024 |
